N-acetylgalactosamine 4,6-bisulfate: galactosamine bisulfate conjugate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 193875 |
| SCHEMBL ID | 3238393 |
| MeSH ID | M0096030 |
| Synonym |
|---|
| 52510-51-7 |
| [(2r,3r,4r,5r)-5-acetamido-2,4-dihydroxy-6-oxo-1-sulfooxyhexan-3-yl] hydrogen sulfate |
| d-galactose, 2-(acetylamino)-2-deoxy-, 4,6-bis(hydrogen sulfate) |
| n-acetylgalactosamine 4,6-bisulfate |
| SCHEMBL3238393 |
| 2-deoxy-2-[(1-hydroxyethylidene)amino]-4,6-di-o-sulfohexose |
| DTXSID20966952 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.34) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||